Metropolis launches AI-powered allergy component testing for various allergy types – ET HealthWorld
Mumbai: Metropolis Healthcare Limited announced the launch of a new testing platform based on Resolved Component Diagnostics (CRD) to support the people of India in the diagnosis of various forms of allergies. Fourth generation allergy testing technology uses artificial intelligence (AI) to help clinicians make sound clinical decisions and provides great insight in selecting and … Read more